Behavioral approaches to the functional assessment of NMDA-mediated neural transmission in intact mice

Clinical Neuropharmacology

Volumn 20, Issue 5, 1997, Pages 375-384

  Deutsch, Stephen I ^a,b   Rosse, Richard B ^a,b   Mastropaolo, John ^a  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Behavior; MK 801; Mouse; NMDA

Indexed keywords

3 (2 CARBOXYPIPERAZIN 4 YL)PROPYL 1 PHOSPHATE; 7 NITROINDAZOLE; CLOZAPINE; DIZOCILPINE; FLURAZEPAM; GUANYLATE CYCLASE INHIBITOR; HALOPERIDOL; METHYLENE BLUE; MILACEMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL MODEL; DISEASE PREDISPOSITION; GENE LOCUS; MENTAL DISEASE; MOUSE; NEUROPHARMACOLOGY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

EID: 0030880953     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199710000-00001     Document Type: Review

References (33)

1. Corbett R, Camacho F, Woods AT, et al. Antipsychotic agents antagonize noncompetitive N-methyl-Daspartate antagonist-induced behaviors Psychoparmacology 1995;120:67-74.
2. Deutsch SI, Morihisa JM. Glutamatergic abnormalities in Alzheimer's disease and a rationale for clinical trials with L-glutamate. Clin Neuropharmacol 1988;11:18-35.
3. Deutsch SI, Mastropaolo J, Schwartz BL, Rosse RB, Morihisa JM. A "glutamatergic hypothesis" of schizophrenia: rationale for pharmacotherapy with glycine. Clin Neuropharmacol 1989;12:1-13.
4. Deutsch SI, Hitri A. Measurement of an explosive behavior in the mouse, induced by MK-801, a PCP analogue. Clin Neuropharmacol 1993;16:251-7.
5. A receptor complex and potentiates flurazepam's antiseizure efficacy. Pharmacol Biochem Behav 1995;51:909-15.
6. Deutsch SI, Rosse RB, Morn C, Koetzner L, Mastropaolo J. Interference with nitric oxide production and action potentiates the antiseizure efficacy of flurazepam. Pharmacol Biochem Behav 1995;51:133-7.
7. Leeson PD, Iversen LL. The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential. J Med Chem 1994;37:4053-67.
8. Norris DO, Mastropaolo J, O'Connor DA, Novitzki MR, Deutsch SI. Glycinergic interventions potentiate the ability of MK-801 to raise the threshold voltage for tonic hindlimb extension in mice. Pharmacol Biochem Behav 1992;43:6019-12.
9. Norris DO, Mastroapolo J, O'Connor DA, Cohen JM, Deutsch SI. A glycinergic intervention potentiates the antiseizure efficacies of MK-801, flurazepam, and carbamazepine. Neurochem Res 1994;19:161-5.
10. Nowak G, Trullas R, Layer RT, Skolnick P, Paul IA. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. J Pharmacol Exp Ther 1993;265:1380-6.
11. Paul IA, Layer RT, Skolnick P, Nowak G. Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine. Eur J Pharmacol-Mol Pharmacol 1993;247:305-11.
12. Paul IA, Nowak G, Layer RT, Popik P, Skolnick P. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. J Pharmacol Exp Ther 1994;269:95-102.
13. 3H-MK-801 binding in Alzheimer's disease. J Neurochem 1989;53:698-704.
14. Steefe JE, Palmer AM, Stratmann GC, Bowen DM. The N-methyl-D-aspartate receptor complex in Alzheimer's disease: reduced regulalion by glycine but not zinc. Brain Res. 1989;500:369-73.
15. Akinci MK, Johnston GAR. Sex differences in acute swim stress-induced changes in the binding of MK-801 to the NMDA subclass of glutamate receptors in mouse forebrain. J Neurochem 1993;61:2290-3.
16. Nowak G, Redmond A, McNamara M, Paul IA. Swim stress increases the potency of glycine at the N-methyl-D-aspartate receptor complex. J Neurochem 1995;64:925-7.
17. McBain CJ, Mayer ML. N-methyl-D-aspartic acid receptor structure and function. Physiol Rev 1994;74:723-60.
18. Foster AC, Wong EHF. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain. Br J Pharmacol 1987;91:403-9.
19. Plotter AW, Stratmann GC, Francis PT, Lowe SL, Bertolucci PHF, Bowen DM. Characterization of the glycine modulatory site ol the N-methyl-D-aspartate receptor-ionophore complex in human brain. J Neurochem 1991;56:299-310.
20. 3H-Labelled MK-801 binding to the excitatory amino acid receptor complex from rat brain is enhanced by glycine. Proc Natl Acad Sci USA 1987;84:7744-8.
21. 3H-TCP binding to rat cortical membranes. Neurosci Lett 1987;83:313-7.
22. 3H-MK-801 binding to the NMDA receptor in rat brain. Eur J Pharmacol 1987;142:487-8.
23. Kleckner NW, Dingledine R. Requirement for glycine in activation ol NMDA receptors expressed in Xenopus oocytes. Science 1988;241:835-7.
24. Lynch DR, Anegawa NJ, Verdoorn T, Pritchett DB. N-methyl-D-aspartate receptors: different subunit requiremertls for binding of glutamate antagonists, glycine antagonists, and channel blocking agents. Mol Pharmacol 1994;45:540-5.
25. Ferrer-Montiel AV, Montal M. Pentameric subunit stoichiometry of a neuronal glutamate receptor. Proc Natl Acad Sci USA 1996;93:2741-4.
26. Breink I, Danysz W, Parsons CG, Mutschler E. Different binding affinities ot NMDA receptor channel blockers in various brain regions indication of NMDA receptor heterogeneity. Neuropharmacology 1995;34:533-40.
27. Yamakura T, Mori H, Masaki H, Shimioji K, Mishina M. Different senstitivities of NMDA receptor channel subtypes to non-competitive antagonists Neuroreport 1993;4:687-90.
28. Deutsch SI, Panchision DM, Rosse RB, Novitzki Mr, Miller LP. Mastropaolo J. Interaction of cholinergic and glutamatergic transmission in the hippocampus: an in vitro autoradiographic receptor analysis. Neurosci Lett 1990;118:124-7.
29. Rosse RB, Mastropaolo J. Sussman DM, Koetzner L, Morn CB, Deutsch SI. Computerized measurement of MK-801-elicited popping and hyperactivity in mice. Neuropharmacol 1995;18:448-57.
30. Deutsch SI, Rosse RB, Riggs RL, Koetzner L, Mastropaolo J. The competitive NMDA antagonist CPP blocks MK-801-elicited popping behavior in mice. Neuropsychopharmacology 1996;18:329-31.
31. Deutsch SI, Rosse RB, Paul SM, Riggs RL, Mastropaolo J. Inbred mouse strains differ in senstivity to "popping" behavior elicited by MK-801. Pharmacol Biochem Behav 1997;57:315-7.
32. Crabbe JC, Belknap JK, Buck KJ. Genetic animal models of alocohol and drug abuse. Science 1994;264:1715-23.
33. Deutsch SI, Rosse RB, Paul SM, et al. 7-Nitroindazole and methylene blue, inbibitors of neuronal nitric oxide synthase and NO-stimulated guanylate cyclase, block MK-801 elicited behaviors in mice. Neuropsychopharmacology 1996;15:37-43.